- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CU: COPPER (II) ION(Non-covalent)
- 2 x MN: MANGANESE (II) ION(Non-covalent)
MN.2: 6 residues within 4Å:- Chain A: K.48, D.451, F.452, D.453, D.592, I.593
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.451, A:F.452, A:D.453, A:D.592, A:I.593, H2O.7
MN.54: 6 residues within 4Å:- Chain B: K.48, D.451, F.452, D.453, D.592, I.593
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.451, B:F.452, B:D.453, B:D.592, B:I.593, H2O.13
- 4 x XE: XENON(Non-covalent)
XE.3: 7 residues within 4Å:- Chain A: F.452, V.508, Y.523, R.524, L.525, M.595, L.622
No protein-ligand interaction detected (PLIP)XE.4: 5 residues within 4Å:- Chain A: I.405, L.407, Y.446, I.601, T.618
No protein-ligand interaction detected (PLIP)XE.55: 6 residues within 4Å:- Chain B: F.452, V.508, Y.523, R.524, L.525, L.622
No protein-ligand interaction detected (PLIP)XE.56: 5 residues within 4Å:- Chain B: I.405, L.407, Y.446, I.601, T.618
No protein-ligand interaction detected (PLIP)- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 3 residues within 4Å:- Chain A: N.131, S.133, E.134
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.131, A:S.133
NAG.6: 7 residues within 4Å:- Chain A: N.558, T.560, E.561, W.581, Q.584, R.586
- Ligands: IOD.48
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.558, A:E.561
NAG.57: 3 residues within 4Å:- Chain B: N.131, S.133, E.134
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.131, B:S.133, B:S.133, B:E.134
NAG.58: 6 residues within 4Å:- Chain B: N.558, T.560, E.561, W.581, Q.584, R.586
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.558, B:E.561, B:Q.584, B:Q.584, B:R.586
- 94 x IOD: IODIDE ION(Non-functional Binders)
IOD.7: 6 residues within 4Å:- Chain A: G.500, I.529, P.530
- Chain B: G.500, I.529, P.530
Ligand excluded by PLIPIOD.8: 1 residues within 4Å:- Chain A: R.470
Ligand excluded by PLIPIOD.9: 4 residues within 4Å:- Chain A: L.114, Y.118, K.185, I.186
Ligand excluded by PLIPIOD.10: 4 residues within 4Å:- Chain A: P.64, N.83, R.85, I.86
Ligand excluded by PLIPIOD.11: 5 residues within 4Å:- Chain A: G.215, P.216
- Chain B: N.242, Y.263, L.265
Ligand excluded by PLIPIOD.12: 3 residues within 4Å:- Chain A: K.66, N.83, V.90
Ligand excluded by PLIPIOD.13: 3 residues within 4Å:- Chain A: K.217, H.219
- Chain B: Q.227
Ligand excluded by PLIPIOD.14: 4 residues within 4Å:- Chain A: P.46, E.47, H.50, I.63
Ligand excluded by PLIPIOD.15: 5 residues within 4Å:- Chain A: P.226, Q.227, R.640, V.642
- Chain B: S.220
Ligand excluded by PLIPIOD.16: 4 residues within 4Å:- Chain A: N.549, Y.550, W.553, A.579
Ligand excluded by PLIPIOD.17: 6 residues within 4Å:- Chain A: D.250, A.253, V.256, K.276, K.562, W.563
Ligand excluded by PLIPIOD.18: 3 residues within 4Å:- Chain A: T.14, H.236, Y.329
Ligand excluded by PLIPIOD.19: 3 residues within 4Å:- Chain A: I.89, S.91, D.92
Ligand excluded by PLIPIOD.20: 5 residues within 4Å:- Chain A: P.289, E.291, Y.294
- Chain B: S.476, K.477
Ligand excluded by PLIPIOD.21: 4 residues within 4Å:- Chain A: G.456, T.457, H.458, N.510
Ligand excluded by PLIPIOD.22: 5 residues within 4Å:- Chain A: G.500, L.501, A.502, P.503
- Chain B: H.532
Ligand excluded by PLIPIOD.23: 4 residues within 4Å:- Chain A: K.396, S.400, K.402, E.621
Ligand excluded by PLIPIOD.24: 4 residues within 4Å:- Chain A: E.16, E.17, A.20, L.84
Ligand excluded by PLIPIOD.25: 3 residues within 4Å:- Chain A: L.52, R.272, G.456
Ligand excluded by PLIPIOD.26: 5 residues within 4Å:- Chain A: I.418, I.424, K.425, E.426, L.428
Ligand excluded by PLIPIOD.27: 3 residues within 4Å:- Chain A: R.586, E.587, K.591
Ligand excluded by PLIPIOD.28: 3 residues within 4Å:- Chain A: P.212, P.213, F.214
Ligand excluded by PLIPIOD.29: 5 residues within 4Å:- Chain A: Y.40, V.70, P.101, I.102, R.252
Ligand excluded by PLIPIOD.30: 4 residues within 4Å:- Chain A: P.289, T.290
- Chain B: S.475, S.476
Ligand excluded by PLIPIOD.31: 2 residues within 4Å:- Chain A: P.30, N.33
Ligand excluded by PLIPIOD.32: 3 residues within 4Å:- Chain A: R.35, N.74, S.75
Ligand excluded by PLIPIOD.33: 4 residues within 4Å:- Chain A: R.371, L.637, S.638
- Chain B: R.317
Ligand excluded by PLIPIOD.34: 2 residues within 4Å:- Chain A: P.119, P.120
Ligand excluded by PLIPIOD.35: 2 residues within 4Å:- Chain A: K.421, D.422
Ligand excluded by PLIPIOD.36: 4 residues within 4Å:- Chain A: F.214, G.215, K.217
- Chain B: L.637
Ligand excluded by PLIPIOD.37: 4 residues within 4Å:- Chain A: S.237, F.245, H.246, L.259
Ligand excluded by PLIPIOD.38: 3 residues within 4Å:- Chain A: P.64, R.65, R.85
Ligand excluded by PLIPIOD.39: 4 residues within 4Å:- Chain A: K.48, D.49, L.52, T.457
Ligand excluded by PLIPIOD.40: 4 residues within 4Å:- Chain A: N.352, I.353
- Chain B: R.379, L.615
Ligand excluded by PLIPIOD.41: 4 residues within 4Å:- Chain A: K.463, I.497, A.504, L.506
Ligand excluded by PLIPIOD.42: 4 residues within 4Å:- Chain A: H.57, P.58, T.59, L.60
Ligand excluded by PLIPIOD.43: 4 residues within 4Å:- Chain A: E.369, S.370
- Chain B: I.314, R.317
Ligand excluded by PLIPIOD.44: 3 residues within 4Å:- Chain A: R.53, T.56, H.57
Ligand excluded by PLIPIOD.45: 5 residues within 4Å:- Chain A: L.10, D.45, P.46, Y.275, K.276
Ligand excluded by PLIPIOD.46: 4 residues within 4Å:- Chain A: I.112, K.113, L.116
- Chain B: P.363
Ligand excluded by PLIPIOD.47: 5 residues within 4Å:- Chain A: I.497, I.499, G.500, A.504, L.506
Ligand excluded by PLIPIOD.48: 4 residues within 4Å:- Chain A: Y.557, N.558, R.559
- Ligands: NAG.6
Ligand excluded by PLIPIOD.49: 4 residues within 4Å:- Chain A: D.106, S.332, A.333, N.334
Ligand excluded by PLIPIOD.50: 6 residues within 4Å:- Chain A: T.164, V.165, E.204, Y.205, Q.206, K.209
Ligand excluded by PLIPIOD.51: 4 residues within 4Å:- Chain A: L.466, E.505
- Chain B: H.602
- Ligands: IOD.106
Ligand excluded by PLIPIOD.52: 3 residues within 4Å:- Chain A: P.320, P.321
- Chain B: Y.350
Ligand excluded by PLIPIOD.59: 5 residues within 4Å:- Chain A: N.242, Y.263, L.265
- Chain B: G.215, P.216
Ligand excluded by PLIPIOD.60: 4 residues within 4Å:- Chain B: P.64, N.83, R.85, I.86
Ligand excluded by PLIPIOD.61: 2 residues within 4Å:- Chain B: N.83, V.90
Ligand excluded by PLIPIOD.62: 4 residues within 4Å:- Chain B: G.456, T.457, H.458, N.510
Ligand excluded by PLIPIOD.63: 6 residues within 4Å:- Chain A: T.222, W.644
- Chain B: H.224, P.226, V.642, P.645
Ligand excluded by PLIPIOD.64: 6 residues within 4Å:- Chain B: D.250, A.253, V.256, K.276, K.562, W.563
Ligand excluded by PLIPIOD.65: 4 residues within 4Å:- Chain B: P.46, E.47, H.50, I.63
Ligand excluded by PLIPIOD.66: 3 residues within 4Å:- Chain B: R.586, E.587, K.591
Ligand excluded by PLIPIOD.67: 4 residues within 4Å:- Chain B: S.237, F.245, H.246, L.259
Ligand excluded by PLIPIOD.68: 2 residues within 4Å:- Chain B: P.212, P.213
Ligand excluded by PLIPIOD.69: 4 residues within 4Å:- Chain B: K.463, I.497, A.504, L.506
Ligand excluded by PLIPIOD.70: 3 residues within 4Å:- Chain B: T.14, H.236, Y.329
Ligand excluded by PLIPIOD.71: 3 residues within 4Å:- Chain B: L.52, R.272, G.456
Ligand excluded by PLIPIOD.72: 3 residues within 4Å:- Chain B: K.396, K.402, E.621
Ligand excluded by PLIPIOD.73: 5 residues within 4Å:- Chain B: I.418, I.424, K.425, E.426, L.428
Ligand excluded by PLIPIOD.74: 3 residues within 4Å:- Chain B: P.212, P.213, F.214
Ligand excluded by PLIPIOD.75: 4 residues within 4Å:- Chain B: L.19, A.20, T.23, R.87
Ligand excluded by PLIPIOD.76: 2 residues within 4Å:- Chain B: K.421, D.422
Ligand excluded by PLIPIOD.77: 4 residues within 4Å:- Chain B: H.57, P.58, T.59, L.60
Ligand excluded by PLIPIOD.78: 3 residues within 4Å:- Chain B: R.35, N.74, S.75
Ligand excluded by PLIPIOD.79: 5 residues within 4Å:- Chain B: L.221, T.222, S.223, P.321
- Ligands: IOD.103
Ligand excluded by PLIPIOD.80: 4 residues within 4Å:- Chain B: K.48, D.49, L.52, T.457
Ligand excluded by PLIPIOD.81: 5 residues within 4Å:- Chain B: Y.40, V.70, P.101, I.102, R.252
Ligand excluded by PLIPIOD.82: 4 residues within 4Å:- Chain B: E.16, E.17, A.20, L.84
Ligand excluded by PLIPIOD.83: 4 residues within 4Å:- Chain A: S.476, K.477
- Chain B: E.291, Y.294
Ligand excluded by PLIPIOD.84: 3 residues within 4Å:- Chain A: Q.227
- Chain B: K.217, H.219
Ligand excluded by PLIPIOD.85: 4 residues within 4Å:- Chain B: N.549, Y.550, W.553, A.579
Ligand excluded by PLIPIOD.86: 5 residues within 4Å:- Chain B: I.72, S.75, F.100, R.152, D.182
Ligand excluded by PLIPIOD.87: 4 residues within 4Å:- Chain A: H.532
- Chain B: G.500, A.502, P.503
Ligand excluded by PLIPIOD.88: 3 residues within 4Å:- Chain B: I.424, K.425, E.426
Ligand excluded by PLIPIOD.89: 3 residues within 4Å:- Chain B: W.144, F.145, E.147
Ligand excluded by PLIPIOD.90: 4 residues within 4Å:- Chain B: L.114, Y.118, K.185, I.186
Ligand excluded by PLIPIOD.91: 4 residues within 4Å:- Chain A: R.317
- Chain B: R.371, L.637, S.638
Ligand excluded by PLIPIOD.92: 4 residues within 4Å:- Chain A: L.637
- Chain B: F.214, G.215, K.217
Ligand excluded by PLIPIOD.93: 3 residues within 4Å:- Chain A: H.602
- Chain B: L.466, E.505
Ligand excluded by PLIPIOD.94: 4 residues within 4Å:- Chain B: K.15, L.19, T.336, P.337
Ligand excluded by PLIPIOD.95: 3 residues within 4Å:- Chain A: K.635
- Chain B: Q.210, S.211
Ligand excluded by PLIPIOD.96: 7 residues within 4Å:- Chain B: T.173, G.174, R.192, D.193, E.195, E.292, K.414
Ligand excluded by PLIPIOD.97: 4 residues within 4Å:- Chain A: P.363
- Chain B: I.112, K.113, L.116
Ligand excluded by PLIPIOD.98: 3 residues within 4Å:- Chain B: P.64, R.65, R.85
Ligand excluded by PLIPIOD.99: 5 residues within 4Å:- Chain B: L.10, D.45, P.46, Y.275, K.276
Ligand excluded by PLIPIOD.100: 4 residues within 4Å:- Chain A: R.379, L.615
- Chain B: N.352, I.353
Ligand excluded by PLIPIOD.101: 3 residues within 4Å:- Chain B: Q.7, P.9, R.65
Ligand excluded by PLIPIOD.102: 4 residues within 4Å:- Chain A: N.519
- Chain B: K.421, K.431, L.432
Ligand excluded by PLIPIOD.103: 6 residues within 4Å:- Chain A: V.642
- Chain B: T.222, S.223, P.321, H.322
- Ligands: IOD.79
Ligand excluded by PLIPIOD.104: 5 residues within 4Å:- Chain B: I.497, I.499, G.500, A.504, L.506
Ligand excluded by PLIPIOD.105: 5 residues within 4Å:- Chain B: V.165, E.204, Y.205, Q.206, K.209
Ligand excluded by PLIPIOD.106: 6 residues within 4Å:- Chain A: L.466, P.503, A.504, E.505
- Chain B: H.602
- Ligands: IOD.51
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Duff, A.P. et al., Using Xenon as a Probe for Dioxygen-Binding Sites in Copper Amine Oxidases. J.Mol.Biol. (2004)
- Release Date
- 2004-11-17
- Peptides
- AMINE OXIDASE, COPPER CONTAINING: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CU: COPPER (II) ION(Non-covalent)
- 2 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x XE: XENON(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 94 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Duff, A.P. et al., Using Xenon as a Probe for Dioxygen-Binding Sites in Copper Amine Oxidases. J.Mol.Biol. (2004)
- Release Date
- 2004-11-17
- Peptides
- AMINE OXIDASE, COPPER CONTAINING: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B